METHODS FOR TREATING NEOPLASIA

PROBLEM TO BE SOLVED: To provide methods for treating cancer.SOLUTION: Disclosed herein is a method for ameliorating cancer in a subject comprising administering an effective amount of IL-2 fusion protein and one or more therapeutic agents to a subject in need thereof thereby ameliorating cancer. In...

Full description

Saved in:
Bibliographic Details
Main Authors WEN JINGHAI, PETER RHODE, WONG HING C, XU WENXIN
Format Patent
LanguageEnglish
Japanese
Published 08.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide methods for treating cancer.SOLUTION: Disclosed herein is a method for ameliorating cancer in a subject comprising administering an effective amount of IL-2 fusion protein and one or more therapeutic agents to a subject in need thereof thereby ameliorating cancer. In one embodiment, the IL-2 fusion protein does not specifically target or bind to the cancer. In another embodiment, the IL-2 fusion protein comprises a T cell receptor (TCR) domain. In yet another embodiment, the T cell receptor domain is a single chain T cell receptor.SELECTED DRAWING: Figure 1 【課題】癌を治療する方法の提供。【解決手段】有効量のIL−2融合タンパク質および1つまたは複数の治療薬を、それを必要とする被験者に投与し、これにより癌を改善することを含む、被験者において癌を改善する方法。前記IL−2融合タンパク質が癌を特異的に標的としないまたは癌に結合しない、前記方法。前記IL−2融合タンパク質がT細胞受容体(TCR)ドメインを含む、前記方法。前記T細胞受容体ドメインが一本鎖T細胞受容体である、前記方法。【選択図】図1
AbstractList PROBLEM TO BE SOLVED: To provide methods for treating cancer.SOLUTION: Disclosed herein is a method for ameliorating cancer in a subject comprising administering an effective amount of IL-2 fusion protein and one or more therapeutic agents to a subject in need thereof thereby ameliorating cancer. In one embodiment, the IL-2 fusion protein does not specifically target or bind to the cancer. In another embodiment, the IL-2 fusion protein comprises a T cell receptor (TCR) domain. In yet another embodiment, the T cell receptor domain is a single chain T cell receptor.SELECTED DRAWING: Figure 1 【課題】癌を治療する方法の提供。【解決手段】有効量のIL−2融合タンパク質および1つまたは複数の治療薬を、それを必要とする被験者に投与し、これにより癌を改善することを含む、被験者において癌を改善する方法。前記IL−2融合タンパク質が癌を特異的に標的としないまたは癌に結合しない、前記方法。前記IL−2融合タンパク質がT細胞受容体(TCR)ドメインを含む、前記方法。前記T細胞受容体ドメインが一本鎖T細胞受容体である、前記方法。【選択図】図1
Author WONG HING C
WEN JINGHAI
XU WENXIN
PETER RHODE
Author_xml – fullname: WEN JINGHAI
– fullname: PETER RHODE
– fullname: WONG HING C
– fullname: XU WENXIN
BookMark eNrjYmDJy89L5WSQ83UN8fB3CVZw8w9SCAlydQzx9HNX8HP1D_BxDPZ05GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGFobmRiaGJo7GRCkCANEHI4g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 新生物を治療するための方法
ExternalDocumentID JP2018172414A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2018172414A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:12:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2018172414A3
Notes Application Number: JP20180126173
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181108&DB=EPODOC&CC=JP&NR=2018172414A
ParticipantIDs epo_espacenet_JP2018172414A
PublicationCentury 2000
PublicationDate 20181108
PublicationDateYYYYMMDD 2018-11-08
PublicationDate_xml – month: 11
  year: 2018
  text: 20181108
  day: 08
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies ALTOR BIOSCIENCE CORP
RelatedCompanies_xml – name: ALTOR BIOSCIENCE CORP
Score 3.2981317
Snippet PROBLEM TO BE SOLVED: To provide methods for treating cancer.SOLUTION: Disclosed herein is a method for ameliorating cancer in a subject comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title METHODS FOR TREATING NEOPLASIA
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181108&DB=EPODOC&locale=&CC=JP&NR=2018172414A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTJLSkpKTk7TNU8xS9IFtogNdRNTgQ25NLM0g2SzVGCT3BS0d9jXz8wj1MQrwjSCiSEbthcGfE5oOfhwRGCOSgbm9xJweV2AGMRyAa-tLNZPygQK5du7hdi6qEF7x8DqytDAQs3FydY1wN_F31nN2dnWK0DNLwgiZw6srkwcmRlYQe1o0EH7rmFOoG0pBch1ipsgA1sA0Li8EiEGpqxEYQZOZ9jVa8IMHL7QGW8gE5r5ikUY5HxdQzz8XYIVgB03hZAgV8cQTz93BT9X_wAfx2BPR1EGJTfXEGcPXaBF8XBvxXsFIDnKWIyBBdjfT5VgUDCzNExKTEwyNjZITAbN0QKDC9QMADasUoxNLA3TJBmk8RgkhVdWmoELxANvprOQYWApKSpNlQXWqiVJcuDQAADh43bv
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdziLSt2JLu3R7KNL1w7b2iy3K3kbTtaCCDlfx3_dSO93T3kIOLsnB5X6X5HcBuGWEMZbnpaQvCJMQEStSViCQK0kp56RASD7g3OEoJt6TFswGsxa8rbkwdZ3Q77o4InpUjv5e1fv18v8Qy67fVq7u2At2fdy71LDFJjvGcKXIQ9EeG06a2IklWpYRpGI8-ZXpGK40cwd2dV6el2On5zGnpSw3Y4p7CHspqnuvjqD1mnWhY62_XuvCftTceGOzcb7VMfQjh3qJPRUwcRPoxDGpHz8IsZOkoTn1zRO4cR1qeRIONP9b1jxINyalnkIb8_3iDAQyUliWMVWVs5zf0aK5OAxAYLVQtZFSnkNvi6KLrdJr6Hg0CuehHz_24IBLamLd8BLa1edXcYURtmL92jI_mXR53A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHODS+FOR+TREATING+NEOPLASIA&rft.inventor=WEN+JINGHAI&rft.inventor=PETER+RHODE&rft.inventor=WONG+HING+C&rft.inventor=XU+WENXIN&rft.date=2018-11-08&rft.externalDBID=A&rft.externalDocID=JP2018172414A